Search Results - "Garinei, R"

Refine Results
  1. 1
  2. 2

    Sentinel node biopsy in cutaneous melanoma: correlations between melanoma prognostic factors and sentinel node status by Minutilli, E, Giannarelli, D, Anzà, M, Garinei, R, Perri, P, Botti, C, Piarulli, L, Bruno, P, Rea, S, Visca, R, Mottolese, M, Di Filippo, S, Di Filippo, F

    “…This study aims to correlate the most important prognostic factors of primary melanoma with sentinel node (SN) positive for metastases. We have enrolled 84…”
    Get more information
    Journal Article
  3. 3

    Systemic and haemodynamic toxicity after isolated limb perfusion (ILP) with TNF-alpha by Laurenzi, L, Natoli, S, Di Filippo, F, Calamaro, A, Centulio, F, Anzà, M, Cavaliere, F, Marcelli, M E, Garinei, R, Arcuri, E

    “…The aim of this study was to evaluate the systemic and haemodynamic postoperative effects of ILP with medium-low dose of TNF alpha in patients diagnosed with…”
    Get more information
    Journal Article
  4. 4

    Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma by Di Filippo, F, Garinei, R, Anzà, M, Cavaliere, F, Giannarelli, D, Cagol, P P, Rossi, C R, Santinami, M, Deraco, M, Botti, C, Perri, P, Di Filippo, S, Piarulli, L, Bruno, P

    “…Hyperthermic antiblastic perfusion/HAP) has been proven to be an effective neoadjuvant treatment in the treatment of advanced soft tissue limb sarcoma. As a…”
    Get more information
    Journal Article
  5. 5

    Liposomal Doxorubicin in the Perfusional Treatment of Advanced Soft Tissue Limb Sarcoma by Di Filippo, F., Cavaliere, F., Anzà, M., Garinei, R., Botti, C., Perri, P., Di Angelo, P., Patrizi, V., Di Filippo, S., Visca, P.

    Published in Journal of chemotherapy (Florence) (01-11-2004)
    “…Liposome-containing doxorubicin has been employed in the treatment of advanced soft tissue limb sarcoma during hyperthermic perfusion. A phase I-II study was…”
    Get full text
    Journal Article
  6. 6

    Hyperthermic antiblastic perfusion for the treatment of soft tissue limb sarcoma by Di Filippo, F, Giannarelli, D, Botti, C, Carlini, S, Cavaliere, F, Garinei, R, Schiratti, M, Casaldi, V, Tedesco, M, Cavaliere, R

    Published in Annals of oncology (01-04-1992)
    “…Eighty patients with locally advanced, high grade soft tissue sarcoma of the extremities were studied prospectively in order to determine the efficacy of…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Anti-blastic hyperthermic perfusion in the treatment of melanoma of the extremities in the loco-regional diffusion phase by Di Filippo, F, Garinei, R, Anzà, M, Cavaliere, F, Botti, C, Perri, P, Di Filippo, S

    Published in Tumori (01-07-2003)
    “…Primary limb melanoma may recur in terms of satellitosis, in transit metastases and/or regional node involvement. Hyperthermic antiblastic perfusion (HAP)…”
    Get full text
    Journal Article
  12. 12

    TNFa-based isolated hyperthermic limb perfusion (HILP) in the treatment of limb recurrent melanoma: update 16 years after its first clinical application by Di Filippo, F, Cavaliere, F, Garinei, R, Anzà, M, Di Angelo, P, Psaila, A, Piarulli, L, Callopoli, A, Bruno, P, Di Filippo, S, Priore, F

    Published in Journal of chemotherapy (Florence) (01-11-2004)
    “…Hyperthermic Limb Perfusion (HILP) with Tumor Necrosis Factor alpha (TNFalpha) and interferon gamma (IFNgamma) was pioneered by Liénard and Lejeune in 1988…”
    Get full text
    Journal Article
  13. 13

    TNFα-Based Isolated Hyperthermic Limb Perfusion (HILP) in the Treatment of Limb Recurrent Melanoma: Update 16 Years after Its First Clinical Application by Di Filippo, F., Cavaliere, F., Garinei, R., Anzà, M., Di Angelo, P., Psaila, A., Piarulli, L., Callopoli, A., Bruno, P., Di Filippo, S., Priore, F.

    Published in Journal of chemotherapy (Florence) (01-11-2004)
    “…Hyperthermic Limb Perfusion (HILP) with Tumor Necrosis Factor alpha (TNFα) and interferon gamma (IFNγ) was pioneered by Liénard and Lejeune in 1988. TNFα was…”
    Get full text
    Journal Article
  14. 14

    Hyperthermic antiblastic perfusion with TNFalpha and melphalan in stage III limb melanoma patients: A phase I - II SITILO study by Di Filippo, F, Rossi, C R, Garinei, R, Anzà, M, Cavaliere, F, Botti, C, Perri, P, Di Filippo, S, Di Angelo, P, Principi, F, Laurenzi, L

    “…Hyperthermic antiblastic perfusion (HAP) has been proven to be an effective treatment of loco-regional spreading limb melanoma. The mean complete response (CR)…”
    Get more information
    Journal Article
  15. 15

    Hyperthermic antiblastic perfusion in the treatment of locoregional spreading limb melanoma by Di Filippo, F, Garinei, R, Giannarelli, D, Anzà, M, Cavaliere, F, Botti, C, Perri, P, Di Filippo, S, Psaila, A, Callopoli, A, Maialetti, R, Sega, F, Frezza, F, Viticci, C

    “…On the basis of personal experience and a review of the literature, the authors have evaluated the results obtained with hyperthermic antiblastic perfusion…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19

    The application of hyperthermia in regional chemotherapy by Di Filippo, Franco, Anzà, Michele, Rossi, Carlo Riccardo, Cavaliere, Francesco, Botti, Claudio, Lise, Mario, Garinei, Rosa, Giannarelli, Diana, Vasselli, Stefania, Zupi, Gabriella, Cavaliere, Renato

    Published in Seminars in surgical oncology (01-04-1998)
    “…To evaluate the role of hyperthermia combined with chemotherapy in the loco‐regional treatment of tumors, a retrospective analysis was done with 228 limb…”
    Get full text
    Journal Article
  20. 20

    Local hyperthermia and systemic chemotherapy for treatment of recurrent melanoma by Di Filippo, Franco, Carlini, Sandro, Garinei, Rosa, Perri, Pasquale, Anzà, Michele, Ferranti, Francesca, Saracca, Elena, Schiratti, Monica, Cavaliere, Francesco, Cavaliere, Renato

    Published in World journal of surgery (01-05-1995)
    “…Thirty‐two patients with recurrent (skin) or metastatic (skin, mode, or both) melanoma have been treated with a hyperthermiacisplatin regimen. The hyperthermic…”
    Get full text
    Journal Article